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Abstract
Background: Traditional Chinese Medicine (TCM), has over thousands-of-years history of use. Chaihu-Shugan-San (CSS), and
Shen-ling-bai-zhu-San (SLBZS), are famous traditional Chinese herbal medicine formulas, which have been used in China, for the treatment of
many chronic diseases.
Materials and Methods:This study investigated the anti-inflammatory effects of CSS and SLBZS on signaling molecules involved in p38
mitogen-activated protein kinase (p38 MAPK), pathway on hepatocytes of non-alcoholic steatohepatitis (NASH), rats induced by high fat diet.
SD male rats were randomly divided into 8 groups: negative control group, model control group, high (9.6g/kg/day)/low (3.2g/kg/day)-dose CSS
group, high (30g/kg/day)/low (10g/kg/day)-dose SLBZS group, high (39.6g/kg/day)/low (13.2g/kg/day)-dose integrated group. The rats of NASH
model were induced by feeding a high-fat diet. After 16, wks, Hepatocytes were isolated from 6, rats in each group by collagenase perfusion. The
liver histopathological changes and serum inflammatory cytokines TNF-α, IL-6 were determined. The proteins of TLR4, phosphor-p38 MAPK 
and p38 MAPK involved in p38 MAPK signal pathway were assayed.
Results: The statistical data indicated the NASH model rats reproduced typical histopathological features of NASH in human. CSS and SLBZS
ameliorated lipid metabolic disturbance, attenuated NASH progression, decreased the levels of TNF-α and IL-6 in serum, as well as inhibited 
TLR4 protein expression, p38 MAPK phosphorylation, and activation of p38 MAPK. In conclusion, CSS and SLBZS might work as a significant
anti-inflammatory effect on hepatocyte of NASH by inhibiting the activation of TLR4, p-p38 MAPK and p38 MAPK involved in p38 MAPK
signal pathway.
Conclusion: To some extent, CSS and SLBZS may be a potential alternative and complementary medicine to protect against liver injury, alleviate
the inflammation reaction, moderate NASH progression.
Key words: p38 mitogen-activated protein kinase; Toll like receptor 4; Hepatocytes; Non-alcoholic Steatohepatitis; Traditional Chinese
medicine;
Non-standard Abbreviations: Chaihu-Shugan-San (CSS); Shen-ling-bai-zhu-San (SLBZS)
Introduction
Non-alcoholic steatohepatitis (NASH), is a chronic process liver disease characterized by hepatocellular ballooning degeneration and
necroinflammation based on hepatic steatosis (Angulo, 2002; Vanni et al., 2010). It is within an important stage from simple steatosis
development to fibrosis, and cirrhosis in non-alcoholic fatty liver disease (NAFLD) (Kopec et al., 2011). Past studies indicated that the excessive
inflammatory cytokines such as TNF-α (Yimin et al., 2012; Tilg et al., 2000; Kudo et al., 2009; Choi et al., 2005), and IL-6 (Tilg et al., 2000; 
Lalor et al., 2007; Tilg et al., 2010; Ji et al., 2011) exacerbated cell lipid peroxidation and liver injury, promoted NASH progression from different
ways.
Toll like receptor (TLR), a kind of membrane receptor protein, is wildly existed in membrane surface of immunological cells and TLR4 is
one of the members in the known TLR family. TLR4 is the main receptor in the lipopolysaccharide (LPS)-mediate immune responses (Jin et al.,
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2008). Mitogen-activated protein kinases (MAPKs), are a highly conserved family of serine/threonine kinases incluing known ERK 1/2, JNK/
SAPK, p38MAPK, ERK5/BMK1, which are all important signaling molecules in the control of cellular biological effects to extracellular stimuli.
After TLR4 is integrated with LPS, MAPKs cascade reactions are activated and then the p38 MAPK protein is phosphorylated, leading to release
of inflammatory factors and starting cell damage mechanism (Takeda et al., 2004; Liu et al., 2010). It was demonstrated that many nosogenesis of
inflammatory diseases were mediated with TLR4-p38 MAPK signal pathway (Xu et al., 2010; Tian et al., 2011).
In oriental countries, Traditional Chinese Medicine (TCM), has over thousands-of-years history of use. Chaihu-Shugan-San (CSS), an
ancient classical formula from “Jingyue Quanshu” written by Jingyue Zhang of China in 1640 A.D. It is composed of seven Chinese herbs:
Bupleurum chinese DC (6g), Pericarpium citri Reticulatae (6g), Ligusticum chuanxiong Hort (5g), Rhizoma Cyperi (5g), Fructus Aurantii (5g),
Radix Paeonia Alba (5g) and Glycyrrhiza uralensis Fisch (3g). Shen-ling-bai-zhu-San (SLBZS) is also a famous classical formula recorded in
“Taiping Huimin Heji Ju Fang” written by the imperial medical bureau of the Song Dynasty in 1078 A.D. It consists of ten species of medicinal
herbs: Panax Ginseng (15g), Atractylodes Ovata (15g), Poria Cocos (15g), Dioscorea Batatasm (15g), Dolichos Lablab (12g), Coix
Lachryma-jobi (9g), Nelumbo Nucifera (9g), Glycyrrhiza uralensis Fisch (9g), Platycodon Grandiflorum (6g) and Amomum Xanthioides (6g).
Based on the theory of TCM, CSS dredges liver qi, and enhances blood circulation, is prescribed mainly for the liver qi stasis. SLBZS has the
functions of tonifying spleen and stomach qi, and is mainly used for deficiency of spleen and stomach.
Many resent studies have demonstrated that CSS protects against lipid peroxidation (Chen et al., 2004; Li et al., 2010), liver fibrosis (Fu et
al., 2007; Pang et al., 2009), insulin resistance (Xue et al., 2010). And SLBZS is able to inhibit of activities on oxidative stress (You et al., 2012),
lipid peroxidation (Li et al., 2012), and inflammatory reaction (You et al., 2012; Liu et al., 2011). Some of the major compounds from CSS and
SLBZS formula, like saikosaponins (Ge et al., 2011; Chiang et al., 2003; Zheng et al., 2011), total glucosides of paeony (Liu et al., 2012; Zhao et
al., 2012), ginsenoside (Zeng et al., 2011; Li et al., 2011), atractylenolide (Wang et al., 2012), atractylodes macrocephalaon polysaccharide
(Zhang et al., 2011), and Carboxymethylpachymaran (Zhou et al., 2009), also have been identified for their potential protection on liver. Thus, it
is essential to investigate the molecular mechanisms of anti-inflammatory effect of CSS and SLBZS to treat NASH. The paper is the first to study
the anti-inflammatory effect of CSS and SLBZS on signaling molecules involved in p38 MAPK signal pathway in hepatocytes of NASH.
Materials and Methods
Preparation of CSS and SLBZS
CSS is composed of seven Chinese herbs: Bupleurum Chinese DC (6 g), Pericarpium Citri Reticulatae (6 g), Ligusticum chuanxiong Hort
(5 g), Rhizoma Cyperi (5 g), Fructus Aurantii (5 g), Radix Paeonia Alba (5 g) and Glycyrrhiza uralensis Fisch (3 g). SLBZS includes Panax
Ginseng (15 g), Atractylodes Ovata (15g), Poria Cocos (15 g), Dioscorea Batatasm (15 g), Dolichos Lablab (12 g), Coix Lachryma-jobi (9 g),
Nelumbo Nucifera (9 g), Glycyrrhiza uralensis Fisch (9 g), Platycodon Grandiflorum (6 g) and Amomum Xanthioides (6 g). Integrated recipe
contains is the mixture of CSS and SLBZS at a ratio of 1:1. All Chinese medicines were formula granules purchased from Shenzhen Sanjiu
Medical Co., Ltd. (1005001S). The formula granules were dissolved in the distilled water, and preserved at -4℃.
Animals
112 Sprague-Dawley of Specific Pathogen-Free Male rats (6 weeks old, 200 g±20 g) were obtained from the Laboratory Animal Research
Center of Guangzhou University of TCM (Approval No. SCXK (Yue), 2008-0020), Guangdong province, China. The rats were housed under
conditions of controlled temperature (24℃±2℃) and humidity (70 %±10 %) in a 12h-light and 12h-dark cycle (lights on from 8:00 am to 8:00
pm), with free access to diet and water.
Experimental design
After one week adaptive breeding, the rats were randomly divided into 8 groups, 14 rats in each group: negative control group (NC),
model control group (MC), high-dose CSS group (H-CSS), low-dose CSS group (L-CSS), high-dose SLBZS group (H-SLBZS), low-dose SLBZS
group (L-SLBZS), high-dose integrated recipe group (H-IG), low-dose integrated recipe group (L-IG). Rat models of NASH were duplicated
according to method as our previously reported (Yang et al., 2011) with some minor modifications. Negative control group of rats got free access
to a normal chow diet, model control group and treatment groups were fed with high fat diet (HFD), (composed of regular chow 88 %, axungia
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porci 10 %, cholesterol 1.5 %, bile salt 0.5 %). All rats in treatment groups were drenched with decoction (H-CSS: 9.6 g/kg/day, L-CSS: 3.2
g/kg/day, H-SLBZS: 30 g/kg/day, L-SLBZS: 10 g/kg/day, H-IG: 39.6 g/kg/day, L-IG: 13.2 g/kg/day), while the rats in the normal group and
model group were fed with the same dose (10 ml/kg body weight) of distilled water once at 8:00 am everyday. Low-dose equaled human clinical
equivalent dosage, and high-dose was 3-fold volume of low-dose. The treatment lasted for 16 weeks.
At the end of treatment, rats in each group were divided into two groups by table of random number: 8, rats for liver samples collection, 6,
rats for isolation of hepatocytes. All rats were treated in compliance with the Guiding Principles for Animal Experiments and the protocols were
approved by the Animal Experimental Ethnics Committee of Jinan University, China.
Blood lipid and histopathological examination of liver
Total cholesterol (TC) and triglyceride (TG) in the serum were determined with automatic biochemical analyzer (Olympus, Japan). The
paraffin-embedded liver tissue (about 1 cm×0.5 cm×0.5 cm) which selected the same part of the liver, about 0.5 cm from the edge of the right
hepatic lobule, were sliced at a thickness of 4μm and examined by hematoxylin-eosin (HE) staining. The steatosis grade, fibrosis stage and 
inflammation of NASH were evaluated according to the NASH histological scoring system (Kleiner et al., 2005).
Determination of inflammatory cytokines in serum
The levels of TNF-α, IL-6, in serum were measured according to the recommended procedures provided by the enzyme-linked 
immunosorbent assay (ELISA), kits (TNF-α, lot No.E3720-1101-1, Beijing Dake Biotechnology Co., Ltd.; IL-6, lot No.R110407-07A, Shenzhen 
Xinbo Biotechnology Co., Ltd., China).
Hepatocyte isolation, purification and identification
Hepatocytes were isolated from 6 rats in each group by collagenase perfusion as described (Hamelet et al., 2009). After 12hrs, incubation
at 37℃, cells were washed three times with PBS. Non-adherent cells were washed off. The hepatocytes viability was >99 % (as tested by trypan
blue dye exclusion). The purity of hepatocytes was >95 % [as assessed by flow cytometry method using ck-18 antibody according to (Luo et al.,
2008)] (Figure 1).
Figure 1: The purity of hepatocytes assessed by flow cytometry method
M1: Labeling of low concentration marker, FITC: Fluorescein isothiocyanate. The purity of hepatocytes was >95 % (as assessed by flow
cytometry method using anti-ck-18). Negative cell is on the left side of the M1 line. Positive cell (hepatocyte) is inside the M1 line.
Protein extraction and Western blot
Western blotting was used to determine proteins of hepatocytes TLR4, phosphor-p38 MAPK (p-p38 MAPK), p38 MAPK and
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH was used as an internal control. Protein preparations were subjected to 10%
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SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane. After transfer, membrane was blocked in 5 % skim milk in
Tris-Buffered Saline Tween-20 (1.5 mM Tris, 5mM NaCl, 0.1 %Tween20) and incubated overnight at 4℃ with specific primary antibodies. 
Anti-TLR4 was purchased from Santa Cruz Biotechnology (USA). Anti-p38 MAPK, Anti-phosphor-p38 MAPK and GAPDH antibody were
purchased from Cell Signaling Technology (USA). Horseradish peroxidase conjugated goat-anti-rabbit antibody and electro chemical
luminescence reagent (Beyotime Biotechnology, China) were used to detect specific proteins. Blots were scanned and densitometry analysis of
band intensities was measured with gel image processing system.
Statistical analysis
The results were expressed as the mean ±standard deviation (S.D.), unless otherwise indicated. A one-way Analysis of variance (ANOVA)
was used to determine the statistical significance of the differences. Probability value (P) less than 0.05 was considered statistically significant.
All data were analyzed with the Statistical Package for the Social Sciences (SPSS, USA) 13.0 Software.
Results
Effects of CSS and SLBZS on serum TC and TG levels and liver histopathological changes
Elevated serum TC, TG levels and liver histopathological changes indicate hepatic lipid accumulation and lipid metabolic disturbance. As
shown in table 1, the serum TC and TG levels were significantly increased in model group compared to the negative control group (P<0.01). The
group of H-CSS, H-SLBZS, L-SLBZS H-IG and L-IG reduced the serum TC and TG levels compared with model control group (P<0.01,
P<0.05). Liver specimens with HE staining were shown in Figure 2. Sections of liver from model control group scored 12 points had showed
typical NASH features, including microvesicular and macrovesicular steatosis, lobular and portal inflammation, and hepatocyte ballooning
(Figure 2), and there was a significant difference compared with negative control group (P <0.01). The pathological changes in the treatment
groups lightened to different degree as compared with model control group (P<0.01, P<0.05) (Table 2). The results indicated that HFD-induced
rats model of NASH had lipid accumulation and lipid metabolic disturbance obviously. CSS and SLBZS ameliorated lipid metabolic disturbance,
attenuated NASH progression to some extent.
Table 1: Effects of CSS and SLBZS on serum levels of TC and TG
Group TG(mmol/L) TC (mmol/L)
NC 0.67±0.23 1.42±0.29
MC 0.79±0.26a 3.90±0.87a
H-CSS 0.60±0.20b 3.40±0.82
L-CSS 0.64±0.13 4.16±0.63
H-SLBZS 0.58±0.20b 3.35±1.46
L-SLBZS 0.60±0.23b 3.81±0.81
H-IG 0.45±0.15c 2.85±0.51
L-IG 0.44±0.10c 3.14±0.39
Values are means ± S.D. of 8 rats per group; aP<0.01 compared with NC group; bP <0.05, cP <0.01 compared with MC group
Table 2: NASH histological scoring in different groups
Group NASH histological scoring
NC 3.00±1.58
MC 12±1.87a
H-CSS 9.44±1.24b
L-CSS 9.51±1.36b
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H-SLBZS 5.44±1.81c
L-SLBZS 6.00±1.58c
H-IG 5.22±1.07c
L-IG 7.67±1.23c
Values are means ± S.D. of 8 rats per group; aP<0.01 compared with NC group; bP <0.05, cP <0.01 compared with MC group
Figure 2: Histological changes of liver sections in different groups (HE staining 200×)
a: Negative control group (NC), b: Model control group (MC), c: High-dose CSS group (H-CSS), d: Low-dose CSS group (L-CSS), e:
High-dose SLBZS group (H-SLBZS), f: Low-dose SLBZS group (L- SLBZS), g: High-dose integrated recipe group (H-IG), h: Low-dose
integrated recipe group (L-IG). In model control group, liver sections had showed typical NASH features, including microvesicular or
macrovesicular steatosis (vertical arrow), lobular and portal inflammation (horizontal arrow). The pathological changes in the treatment groups
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lightened to different degree as compared with model control group.
Effects of CSS and SLBZS on serum inflammatory cytokine levels
Rising inflammatory cytokine levels of TNF-α and IL-6 are regarded as biomarkers of inflammation. Table 3 showed that levels of TNF-α 
and IL-6 in model control group were higher than that of the negative control group (P <0.01). The treatment groups had lower serum TNF-α and 
IL-6 levels compared with model control group (P<0.01, P<0.05). It is thus clear that CSS and SLBZS had significant anti-inflammatory effect on
the HFD-induced NASH rats in this experiment.
Table 3 Effects of CSS and SLBZS on serum inflammatory cytokine levels
Group TNF-α(pg/ml) IL-6 (pg/ml) 
NC 13.57±4.64 39.28±28.53
MC 28.26±8.60*a 132.81±44.22*a
H-CSS 18.16±5.86b 63.50±34.51b
L-CSS 20.49±7.33b 67.62±27.03b
H-SLBZS 17.43±5.29b 52.81±21.88b
L-SLBZS 20.09±6.59b 60.38±36.21b
H-IG 15.07±6.00c 41.72±32.24c
L-IG 18.29±3.57b 68.35±25.58b
Values are means ± S.D. of 8 rats per group; aP<0.01 compared with negative control group; bP <0.05, cP <0.01 compared with model control
group
Effects of CSS and SLBZS on p38 MAPK signal pathway related proteins in hepatocytes
To explore the mechanism of the anti-inflammatory effect of CSS and SLBZS on hepatocytes of NASH rats, we assayed three important
proteins of TLR4, p-p38 MAPK and p38 MAPK involved in p38 MAPK signal pathway which is one important mediator in inflammatory
response (Alisi et al., 2010; Xu et al., 2010; Tian et al., 2011). Table 4 showed that expression levels of TLR4, p-p38 MAPK and p38 MAPK as
well as the ratio of p-p38 MAPK to total p38 MAPK protein in model control group were significantly higher than those in normal control group,
(P <0.01). Compared to the model group, all treatment groups inhibited the expression levels of TLR4, p-p38 MAPK and p38 MAPK (P<0.01,
P<0.05). And the ratio of p-p38 MAPK to total p38 MAPK protein were decreased obviously (P<0.01, P<0.05). It indicated that p38 MAPK
signal pathway may be activated in hepatocytes of NASH rats. The CSS and SLBZS inhibited activation of p38 MAPK signal pathway in
different degrees.
Figure 3：Western blot analysis of proteins involved in p38 MAPK signal pathway in hepatocytes
a: Negative control group (NC), b: Model control group (MC), c: High-dose CSS group (H-CSS), d: Low-dose CSS group (L-CSS), e: High-dose
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SLBZS group (H-SLBZS), f: Low-dose SLBZS group (L- SLBZS), g: High-dose integrated recipe group (H-IG), h: Low-dose integrated recipe
group (L-IG).
Discussion
NASH is a popular chronic liver disease, and it has been one of the important factors resulting in hepatocirrhosis and liver cancer (Cohen
et al., 2011; Fuchs et al., 2012). Though its etiology of NASH is still remaining unclear, it is considered to be associated with insulin resistance,
lipid metabolic disorders, oxidative stress, lipid peroxidation or secretion of inflammatory cytokines. According to the two hit hypothesis, the first
hit is fat accumulation in liver hepatocytes, which could lead to hepatic steatosis, further as a result of insulin resistance or lipid metabolic
disorders. The second hit is exacerbating factors such as oxidative stress, lipid peroxidation or secretion of inflammatory cytokines which lead to
hepatocyte inflammation, fibrosis and even hepatocirrhosis (Day et al., 1998).
Table 4: Expression of TLR4, p-p38 MAPK and p38 MAPK protein in hepatocytes
Group TLR4／GAPDH p-p38 MAPK／GAPDH p38 MAPK／GAPDH p-p38 MAPK／
p38 MAPK
NC 0.85±0.11 0.40±0.02 1.55±0.20 0.26±0.02
MC 1.40±0.10a 1.69±0.08a 4.14±0.10a 0.41±0.01a
H-CSS 0.86±0.09b 0.75±0.03b 2.64±0.09b 0.28±0.002b
L-CSS 0.75±0.08b 0.69±0.06b 2.79±0.07b 0.25±0.02b
H-SLBZS 0.70±0.04b 0.66±0.06b 2.38±0.08b 0.28±0.016b
L-SLBZS 0.76±0.03b 0.91±0.04b 2.52±0.13b 0.36±0.003c
H-IG 0.64±0.03b 0.46±0.03b 2.03±0.40b 0.23±0.031b
L-IG 1.09±0.13c 0.67±0.02b 2.09±0.09b 0.32±0.004b
Values are means ± S.D. of 6 rats per group; aP<0.01 compared with negative control group; bP <0.01, cP <0.05 compared with model control
group
In the present research, HFD induced rat model of NASH successfully replicated several typical histopathological characteristics of
NASH in human, such as hepatic lipid accumulation, hepatocyte steatosis and inflammatory cell infiltration. It was consistent with the previous
study (Yang et al., 2011; Ji et al., 2011). We showed that CSS and SLBZS decreased the serum level of TG, and ameliorated the symptoms of
inflammation in NASH model rats. Thus, further study is needed to elucidate the anti-inflammatory mechanism of CSS and SLBZS. We
determined several proteins involved in p38 MAPK signal pathway which were closely related with inflammatory reaction and apoptosis (Wagner
et al., 2009). The results demonstrated that activation of TLR4-p38 MAPK signal pathway in hepatocytes was involved in the development of
NASH. CSS and SLBZS successfully suppressed the activation of TLR4, p-p38 MAPK and p38 MAPK involved in p38 MAPK signal pathway.
In conclusion, this study revealed that CSS and SLBZS might work as a significant anti-inflammatory effect on hepatocyte of NASH
induced by HFD by inhibiting the activation of TLR4, p-p38 MAPK and p38 MAPK involved in p38 MAPK signal pathway. CSS and SLBZS
may be a potentially alternative and complementary medicine to protect against liver injury, alleviate the inflammation reaction, moderate NASH
progression. However, some limitation of the present study should be further to explored whether the high-dose Chinese medicines have any side
effects or be in an acceptable margin of safety, and which elements of the Chinese medicines have these special therapeutical effects.
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